Person

Jeffrey Ryan Stewart

EVP, CHIEF COMMERCIAL OFFICER, AbbVie

Current S&P 500 boards
0
Current roles
1
Open-market buys
$1.0M
Open-market sales
$45.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • ABBV
    AbbVie
    EVP, CHIEF COMMERCIAL OFFICER
    since Dec 2018

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 31, 2025ABBVSale33,132$210.54$7.0M
Mar 31, 2025ABBVSale25,700$209.49$5.4M
Mar 18, 2024ABBVSale27,740$178.69$5.0M
Mar 18, 2024ABBVSale26,110$178.85$4.7M
Mar 18, 2024ABBVSale5,099$179.03$913K
Mar 13, 2023ABBVSale21,810$152.30$3.3M
Mar 13, 2023ABBVSale31,315$152.27$4.8M
Mar 24, 2022ABBVSale27,690$159.20$4.4M
Mar 1, 2022ABBVSale2,600$149.04$388K
Mar 1, 2022ABBVSale6,229$147.43$918K
Mar 1, 2022ABBVSale12,659$148.49$1.9M
Dec 15, 2021ABBVSale2,152$128.00$275K
Mar 1, 2021ABBVSale13,773$108.59$1.5M
Dec 29, 2020ABBVSale25,290$105.00$2.7M
May 12, 2020ABBVSale23,024$90.00$2.1M
Aug 16, 2019ABBVBuy15,552$64.44$1.0M

SEC reporting-owner ID (CIK) 1761675 · all filings on EDGAR